Transparency Market Research (http://www.transparencymarketresearch.com) includes new market research report "Thyroid Gland Disorder Market" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 10/30/2014 -- Thyroid gland is located in the lower part of neck and produces and stores hormones that help to regulate blood pressure, heart rate and body temperature. Thyroid hormones are also regulating the essential functions of body cells and maintain functions like metabolism i.e. rate of chemical reaction in the body. Triiodothyronine (T3), thyroxine (T4) and calcitonic are important types of thyroid hormones. Pituitary gland produce thyroid stimulating hormone (TSH) that stimulates the thyroid gland to produce these hormones. The disorder of thyroid gland functions involves abnormal production of thyroid hormones and hence results in condition like hyperthyroidism and hypothyroidism. Hyperthyroidism initiates the excessive production of thyroid hormone. This condition occurs due to variety of disease conditions like graves' disease, toxic adenomas and subacute thyroiditis. In contrast, hypothyroidism is defined as the underproduction of thyroid hormones. Conditions like hashimoto's thyroiditis and exposure to excessive amounts of iodide responsible for hypothyroidism. Blood tests, radioactive iodine uptake tests, thyroid scan thyroid fine needle biopsy and thyroid ultrasound are useful for the diagnosis of thyroid gland disorders. In addition, anti-thyroid medicines, radioiodine, beta-blockers are advised by physicians for the effective treatment of these disorders.
Browse the full Thyroid Gland Disorder Market Report with TOC
The market of thyroid gland disorder can be segmented on the basis of:
By Drug Types
- Levothyroxine Sodium
- Thyrotropin Releasing Hormone
- Thyroid Stimulating Hormone (TSH)
Increasing number of thyroid disorder cases will drive the growth of thyroid gland disorder market. Additionally, prevalence of thyroid disorder is also increasing in emerging regions such as India, China and South East Asia that would further augment the market growth. For example, according to Indian Journal of Endocrinology and Metabolism (IJEM), approximately 42 million people are suffering from the thyroid diseases such as hypothyroidism, hyperthyroidism, iodine deficiency disorder, goiter and thyroid cancer every year. In addition, presence of large number of therapeutics under clinical pipeline will boost the market growth of thyroid gland disorders in near future. Consistent efforts of key companies to develop new therapeutics also stimulate the market growth. For example, Genzyme Corporation is engaged in breakthrough therapies for the thyroid disorder patients. The company is dedicated to develop next generation treatment options, majorly focusing on endocrine diseases. Thus, these types of efforts will establish healthy platform to develop the market and hence drives the market growth. However, high and severe side effects related to thyroid gland disorders therapeutics will hamper the market growth. For example, anti-thyroid medicines may cause severe damage to thyroid gland and destroy the thyroid cells permanently that produces thyroid hormone.
Geographically, North America is considered as the largest market of global thyroid gland disorder due to increasing number of thyroid gland related disorders in this region. For example, according to World Health Organization, approximately 1 in 13 Americans or 20 million people are diagnosed with thyroid disorders ever year. Europe is considered as the second largest market of thyroid gland disorder. The growth is mainly attributed to introduction of novel therapeutics by domiciled key players coupled with continuous efforts of key companies to increase awareness of this disorder among the European people. In addition, Asia-Pacific region is the most lucrative market for thyroid gland disorder because of rising uptake of thyroid gland disorder therapeutics coupled with high prevalence of these disorders.
Various key players contributing to the global thyroid gland disorder therapeutics market include Health Grades, Inc., Genzyme Corporation and others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include:
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Market:
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Enquiry before Buying
Latest Upcoming Reports
90 State Street,
Albany NY - 12207
Browse market research blog: